Citeline company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former Citeline executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Products & Services
Business Development and Regulatory Tools
Description: Intelligence and software tools providing market analysis, regulatory insights, and commercial intelligence for business development and •••••••••• ••••• •• ••• ••••••••• •••••.••••: ••••••••••• ••••••••••, •••••, ••••••• •••••• ••••••••••••, •••• •••••, •••••••••••••••• ••••: •••• •• •••••••• ••••••••••• ••••• ••• •••••••••• ••••• •• ••••••• ••• •••••• ••••••••• ••• ••••••••••• ••••••••, •••••••••• ••••••••••, •••••• •••••••••••, ••• ••••••••• ••••••••••• ••••••••: •••••••••• •• ••••••••, •••••••••• •••••••••• ••••••••••, •••••• ••••••••••• •••••, •••••• •••••••, •••• ••••••••••••, •••••• ••••••••, •••••••••••• •••••••••, ••••••••• ••••• •••••••• •••••••••••
Patient Engagement and Recruitment Services
Description: End-to-end platform and services for patient recruitment, enrollment and engagement across the clinical trial lifecycle.Name: Citeline Co•••••, ••••• ••••••••• ••••••••, ••••••••• ••••••, ••••••••••••, ••• •••••••••••• ••••: •••• •• •••••••• ••••• •••••••• ••• •••• ••• ••••••-••-••••••• •••••••••••, ••••••• •••••••••, ••••••-••-••• ••••••••, ••• ••••• ••••-••••• •••• •• •••••••• ••• •••••• ••••• ••• •••••••••• •••••••••••• ••••••••: ••••••• •••••••• ••••••••••, ••••••••• •••••••••• •••••, ••••••••••• •••••••, •••••••••• ••••••••, ••• ••••••••• •••••••••, •••••-•••••••• ••••••••, •••••• •••••• ••••••••••••, ••••••••• ••• •••••••••• ••••••••••
Clinical Tools
Description: Real-time R&D intelligence platform providing curated global clinical trials, investigator, site and drug development pipeline data to su••••• •••••••• ••••••, •••••••••••, ••• •••••••••• •••••••••.••••: •••••••••, ••••••••••, ••••••••••••••••• ••••: •••• •• •••••••••••••• ••• ••••••• •••••••••, •••• ••• •••••• •••••••• ••••••••, ••••• ••••••••••• ••••••••••, •••••••••••• ••• •••• •••••••••, •••••••• ••••••••••••, ••• •••••••• ••••••••••• ••••••••: •••• •••••••••• ••••••••, •••••••• •••••••••, ••••••• •••••••, •• •••• ••••••••• (••••), ••••• •••••• ••••••••••, •••••••••• ••••••••••• ••••••••, •••••••••••• ••••••••• ••••••••••••, •••• ••••••••• •••••••, •••••• •••••• •••••
Pricing & Go-to-market
Typical Contract Length
••% •• ••••••••• ••• ••• ••••, •••• ••• ••••••••• ••% ••••• ••••••• ••• ••• •••••-•••• •••••••••
Pricing model
Subscription-based SaaS model with modular, data-package licensing structure. Custom enterprise subscriptions are billed annually and tiered by produc• •••••••, •••• •••••, ••• •••• ••••••, •••• ••••••••• ••••••••• ••• ••••••••••• ••••••••••• •••• •• ••% ••• •••/••• •••••••
Average Sales Value
Clinical tools average $100,000 per year (range $25,000-$2,000,000, with most in $50,000-$150,000 range), business development and regulatory tools av••••• $••,••• ••• •••• (••••• $••,•••-$•••,•••), ••• ••••••• •••••••••• ••• ••••••••••• •••••••• ••••••• $•••,••• (••••• $•••,•••-$••,•••,•••)
Average Sales Cycle
•-• ••••• ••• •••••••••••• ••••••••, ••••• •••••• •••••••• •• ••••••• •••••••••• ••• ••••••••••• •••••••• •••• •-• ••••••
Growth Review
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 Citeline | - | ••• '•• | - | USA | A••••••• |
 DRG China In Depth | - | - | - | - | - |
| DRG China In Depth | - | - | - | - | - |
 GlobalData Plc | - | - | - | - | P••••• |
| GlobalData Plc | - | - | - | - | P••••• |
 QuantHealth | - | - | - | - | F•••••••••••• |
| QuantHealth | - | - | - | - | F•••••••••••• |
Experts highlight Citeline's operational execution and market approach, while noting integration execution as a potential constraint.
What does Origin provide on Citeline?
Origin provides a structured company snapshot of Citeline, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of Citeline different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how Citeline operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like Citeline?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like Citeline for investment, partnership, or competitive analysis.
Where does Origin's information on Citeline come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on Citeline?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to Citeline. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing Citeline?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like Citeline.
How is Origin used to analyse post-acquisition risks and priorities for Citeline?
After an acquisition, Origin can help teams understand where value creation may be driven or constrained, including product overlap, customer retention dynamics, and go-to-market integration priorities. It can also highlight areas where Citeline may face competitive pressure or internal execution risk during integration.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like Citeline?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like Citeline, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
Axtria
Cloud-based data analytics and commercial operations platform for life sciences companies to manage data, generate insights, and support decision-making across business functions.
HQ
Ownership
Investors
Aduro
Integrative health and human performance platform for self-insured employers to deliver personalized well-being, mental health, and care solutions